Jane Street’s Agilon Health AGL Stock Holding History

Jane Street’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-468	Closed	-$12.1K	–	10992
2025 Q3	$12.1K	Sell	468 -3,216	-87%	-$121K	﹤0.01%	10568
2025 Q2	$212K	Sell	3,684 -1,616	-30%	-$130K	﹤0.01%	8437
2025 Q1	$574K	Sell	5,300 -568	-10%	-$49.4K	﹤0.01%	6606
2024 Q4	$279K	Sell	5,868 -108	-2%	-$6.53K	﹤0.01%	7856
2024 Q3	$587K	Buy	5,976 +5,424	+983%	+$700K	﹤0.01%	6911
2024 Q2	$90.3K	Sell	552 -4,924	-90%	-$701K	﹤0.01%	8770
2024 Q1	$835K	Buy	5,476 +4,524	+475%	+$753K	﹤0.01%	5730
2023 Q4	$299K	Sell	952 -3,876	-80%	-$1.4M	﹤0.01%	7602
2023 Q3	$2.14M	Buy	4,828 +452	+10%	+$204K	﹤0.01%	3942
2023 Q2	$1.9M	Sell	4,376 -2,644	-38%	-$1.49M	﹤0.01%	4237
2023 Q1	$4.17M	Buy	7,020 +180	+3%	+$101K	﹤0.01%	2698
2022 Q4	$2.76M	Buy	6,840 +5,484	+404%	+$2.57M	﹤0.01%	3354
2022 Q3	$794K	Buy	1,356 +808	+147%	+$484K	﹤0.01%	5851
2022 Q2	$299K	Sell	548 -752	-58%	-$380K	﹤0.01%	7611
2022 Q1	$824K	Buy	1,300 +500	+63%	+$258K	﹤0.01%	6519
2021 Q4	$540K	Hold	800	–	–	﹤0.01%	7111
2021 Q3	$524K	Buy	+800	New	+$683K	﹤0.01%	7192

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NPCM

North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Jane Street's AGL Position: Q1 2026 in Review

Jane Street increased its Agilon Health (AGL) stake by 1,678% in Q1 2026, buying an estimated $231K and bringing the position to 15,113 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #10535.

Jane Street first reported a position in AGL in Q3 2021 and has held it in 17 quarters since. The position peaked at $9.53M in Q1 2023. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

Jane Street held 15,113 shares of Agilon Health worth $120K as of Q1 2026.
Jane Street bought 14,263 Agilon Health shares in Q1 2026, an estimated $231K.
Agilon Health made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10535 holding.
Jane Street first reported a position in Agilon Health in Q3 2021 and has held it in 17 quarters since.
Jane Street's Agilon Health position peaked at $9.53M in Q1 2023.
97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.